Blog - Page 412 of 5644 - QualityStocks

MondayAug 12, 2024 10:57 am

QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Partners with RxSpark to Provide Integrated Solution for Medication Management

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced a strategic partnership with RxSpark, a platform dedicated to providing affordable prescription medications and healthcare services. According to the announcement, this partnership will enhance the patient’s experience by integrating HealthLynked’s advanced healthcare network with RxSpark’s pharmacy discounts and prescription price comparison tool. Through this exciting integration, HealthLynked members can find savings of up to 90% off their medications, easily manage their prescriptions, and ensure timely access to necessary medications. Key benefits include enhanced prescription management, improved access to affordable medications, streamlined healthcare experience, and cost savings for patients. “At HealthLynked,…

MondayAug 12, 2024 10:43 am

QualityStocksNewsBreaks – Upstream Lists Advantages of Trading Powered by Blockchain Tech

Upstream, a MERJ Exchange stock market and global trading app, is powered by blockchain technology, which is self-sufficient and operates continuously. That model means that stock markets could operate 24/7 with instantaneous settlement, which changes the landscape, particularly during market sell-offs. The advantages of that were discussed in a recent Upstream article. The article noted that “this past Monday morning, the Dow Jones Industrial Average fell more than 1,000 points. The Nikkei 225, an index of leading stocks in Tokyo, closed down 5.8% Friday, and then 12.4% on Monday.” The article observed that because of traditional stock-trading hours, an entire…

MondayAug 12, 2024 10:30 am

Clene Inc.’s (NASDAQ: CLNN) Makes Significant Strides in Developing its Lead Agent, CNM-Au8(R), to Address Neurodegenerative Conditions

Clene has conducted five Phase 2 clinical trials, three with long-term extensions, and three expanded access programs (with additional studies ongoing) to evaluate the safety and efficacy of CNM-Au8 The global ALS treatment market is poised for growth, driven by an aging population and limited current treatment options CNM-Au8 works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health, and is at a deficit in neurodegenerative diseases Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative…

MondayAug 12, 2024 9:45 am

Rising Domestic Violence Incidents Represents Expanding Opportunity for EM Tech Innovator SuperCom Ltd. (NASDAQ: SPCB)

Domestic violence worldwide is fostering a concerted response by criminal justice officials and legislators upset by the deadly fallout of offenders who violate court-ordered protective measures for victims Tennessee recently passed a statewide law establishing specific targets for electronic monitoring of offenders via GPS and communication with victims, creating clear and timely awareness of situations in which offenders are in proximity to victims Electronic monitoring technology innovator SuperCom Ltd. has developed a suite of hardware, connectivity, and software components designed to target the market for monitoring domestic violence offenders and alerting their victims to dangers SuperCom recently reported over $11…

MondayAug 12, 2024 9:12 am

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shareholders Approve Plans for Share Consolidation, Name Change

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is planning to consolidate its issued and outstanding class A multiple voting shares and class B subordinate voting shares. The company also has announced a planned name change to Quantum BioPharma Ltd, with a new trading symbol of QNTM. The consolidation, which is part of the company’s efforts to regain compliance with NASDAQ’s minimum bid price, and name change are subject to approval by the NASDAQ exchange; if approved, the changes will be effective Aug. 15, 2024. These…

MondayAug 12, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Secures U.S. Patent Covering Methods For Treating TBI and Preventing Nerve Cell Death With Buntanetap

U.S. Patent No. 12,042,482 specifically addresses traumatic brain injury (“TBI”) treatment with buntanetap, enhancing Annovis Bio’s portfolio that includes various patents and applications for using buntanetap in treating both acute and chronic neurodegenerative diseases and mental illnesses Buntanetap targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43 TBI is one of the major causes of death and disability in the US with annual death rate exceeding 70,000 Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company, announced the issuance of a U.S. patent for treating traumatic brain injury (“TBI”) with…

FridayAug 09, 2024 2:07 pm

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is providing a status report on its investment in Celly Nutrition Corp. A privately held Canadian company, Celly Nu is launching an innovative beverage product designed to assist in expediting alcohol metabolism and faster recovery from alcohol consumption. According to the update, Celly Nu has announced the imminent launch of its revolutionary, great-tasting, scientifically backed product, unbuzzd(TM). The product will be available in 3-pack or 18-pack options, and the compact packages can easily be carried in a pocket…

FridayAug 09, 2024 1:56 pm

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Faces Antitrust Scrutiny Amid Market Dominance

Alphabet (NASDAQ: GOOGL, GOOG), the parent company of Google, is currently facing a challenging period, with antitrust scrutiny at the forefront of its concerns. Despite the complexities surrounding the antitrust ruling, experts from Barron’s suggest that Google’s market dominance is unlikely to be significantly impacted by the label of being a monopolist. However, it’s important to note that other risks loom large, potentially threatening the tech giant’s position. The recent performance of Alphabet Inc.’s stock reflects the company’s current challenges and investor sentiment. With a closing price of $159.89, down $2.15 or -1.32%, the market is reacting to the ongoing developments. The stock’s movement…

FridayAug 09, 2024 10:30 am

Crypto Fest 2024 – Returns for its 6th Edition, Cape Town, South Africa

Join the crypto saga as Crypto Fest returns with its 6th edition, bringing together the dynamic African crypto and blockchain community in the picturesque city of Cape Town, South Africa on October 10-12th, 2024. This year Crypto Fest 2024 expands over three days with the main event on the 11 October taking place at the iconic DHL Stadium, home to the FIFA World Cup in 2010 a centrally located iconic landmark with excellent facilities, accessibility, and a rich legacy. Bitcoin Events has been the proud host of Crypto Fest for the last five years, and has witnessed thousands of attendees…

FridayAug 09, 2024 9:45 am

Astiva Health Inc. Focused on Establishing Lifelong Relationships, Providing Tailored Healthcare Approach to Underserved Populations

Survey indicates sizable proportion of older adult population copes with healthcare costs by skipping treatments, cutting back on basic and essential needs Astiva Health is keenly aware of problems faced by underserved senior population The company strives to bridge healthcare gaps through proactive, culturally responsive solutions As growing numbers of the U.S. population reach age 65, the challenge of adequate healthcare becomes even more critical. In fact, a West Health-Gallup survey reports that some elderly are forgoing needed care because of healthcare costs (https://ibn.fm/pJGqA). Astiva Health, a dynamic and innovative Medicare Advantage Prescription Drug (“MAPD”) health plan, is on a…

Site Search

Company Search